WSJ What’s News Podcast Por The Wall Street Journal arte de portada

WSJ What’s News

WSJ What’s News

De: The Wall Street Journal
Escúchala gratis

OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.
What's News brings you the biggest news of the day, from business and finance to global and political developments that move markets. Get caught up in minutes twice a day on weekdays, then take a step back with our What’s News in Markets wrap-up on Saturday and our What’s News Sunday deep dive.Copyright © Dow Jones & Company, Inc. All Rights Reserved. Política y Gobierno
Episodios
  • Government Shutdown Poised to Become Longest in U.S. History

    Government Shutdown Poised to Become Longest in U.S. History
    Nov 4 2025
    P.M. Edition for Nov. 4. WSJ’s Congress reporter Katy Stech Ferek talks about the latest in negotiations as lawmakers search for a deal to end the shutdown. Spencer Jakab, who writes WSJ’s Markets A.M. newsletter, explains why a famous method of valuing stocks suggests rough years ahead. And it’s Election Day in the U.S. Head to WSJ’s live blog for more coverage of key races in New York City, New Jersey and Virginia. Sabrina Siddiqui hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    12 m
  • What’s News in Earnings: Who Is Winning the Obesity-Drug Arms Race?

    What’s News in Earnings: Who Is Winning the Obesity-Drug Arms Race?
    Nov 4 2025
    Bonus Episode for Nov. 4. The weight-loss-drug arms race is only heating up, as Novo Nordisk attempts to snatch drugmaker Metsera away from Pfizer. But can either company compete with Zepbound seller Eli Lilly? WSJ reporter Peter Loftus discusses what earnings from Big Pharma, including AbbVie, Bristol Myers Squibb and Merck, say about the future of the industry and how companies are responding to President Trump’s drug-pricing plans, including TrumpRx. WSJ Heard on the Street columnist David Wainer hosts this special bonus episode of What's News in Earnings, where we dig into companies’ earnings reports and analyst calls to find out what’s going on under the hood of the American economy. Sign up for the WSJ's free Markets A.M. newsletter. Further Reading: Novo Nordisk Sweetens Offer for Metsera - WSJ Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk The Day Pharma’s Weight-Loss Gold Rush Intensified Pfizer Profit Falls Amid Lower Covid-19 Drug Demand Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera Novo Nordisk to Shake Up Board After Obesity-Market Challenges Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings AbbVie Lifts Profit Outlook as Sales Rise Bristol Myers Squibb Profit Soars, Raises Revenue Guidance Merck Profit Rises on Strong Keytruda Demand GSK Lifts Guidance After Specialty Medicines Boost Sales Novartis Expects to Ride Out Patent Losses With Sales, Profit Growth Ahead Biogen Cuts Full-Year Earnings Guidance, Despite Third-Quarter Profit Rise J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    8 m
  • Trump Backs Cuomo in New York Mayoral Race

    Trump Backs Cuomo in New York Mayoral Race
    Nov 4 2025
    A.M. Edition for Nov. 4. It is election day with voters heading to the polls in states including New York, Virginia and New Jersey. WSJ’s John McCormick says that although Democrats are expected to win all three races, it will not necessarily ease the divided party’s troubles. Plus, WSJ’s Gavin Bade says there is a lot at stake for President Trump as his tariffs are set to go before the Supreme Court. And two major investors reject Elon Musk’s $1 trillion pay deal. Caitlin McCabe hosts. Sign up for the WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    15 m

Featured Article: The Best Investing Podcasts to Help You Build Your Portfolio


For beginner investors, we’ve compiled a list of podcasts that are perfect for getting your feet in the door. For those of you who are already familiar with investing and are looking for more specific information from experts to take your investments to the next level, there are great podcasts available for you too. This list includes the best investing podcasts—for beginners, for choosing stocks and funds, for expert investors, and for keeping up with the news.

Featured Article The Best Investing Podcasts to Help You Build Your Portfolio
Todas las estrellas
Más relevante
The last several days the podcast is updated 24 hours late. In other words, I'm getting yesterday morning's news this morning. When I checked with Audible, they confirmed that the podcast hadn't sent a new update. What's going on?

Updates 24 hours late???

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
I wish this gave more information on other big topics and less on Covid 19. I know that I'm not the only person tired of hearing it everywhere we turn.

Same Covid stories over and over

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
This is a downgrade from the daily digests. Paying premium for ads?! And I don’t want opinions, want reporting in the news.

Ads and Commentary?

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
Excellent overview of what market participants want to know. Unfortunately, it doesn’t arrive consistently every morning, so hard to depend on it. Some days doesn’t show up at all when I check at 9 am, while it used to be available at 5:30 am. NY time. Disappointed.

Good content… when it arrives.

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
Why is it delayed by at least a full day or more now since the new logo?

Why isitt a day late now?

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
I will not renew when my subscription ends in Nov. A prime reason for listening is now gone.

The decision to drop the daily WSJ and New York Times deprives your listeners of a prime source of excellent content. I will no

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
would like a more neutral pro America version. how to run a country from a big government view is not helpful. or the censorship ads of different people

red Chinese point of view

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
I switched to this podcast after the WSJ Digest was discontinued. This is not that. If you are looking for a bunch of headlines with brief (!) comments then this is fine. I miss the more in-depth detail of a full article. This doesn't even save time, with the introductions and ad time then cover nearly as many topics in the same time but with less information.

Headlines, not reporting

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
This podcast does NOT take the place of WSJ What’s In The News. It is not enjoyable to listen to and I have to listen to adds!!!

Why the change?

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
I enjoy the presentation, but the delivery is unreliable. Stories for a period are delivered on time, then not. The function to find the story you want to listen to, often does not respond. Very disappointing.

Unreliable delivery

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
Ver más opiniones